Atlas Trials

Advanced ER-Positive HER2-Negative Breast Cancer

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Advanced ER-Positive HER2-Negative Breast Cancer

RecordFirmDate
A Study to Investigate Efficacy and Safety With Oral AZD9833 Compared With Intramuscular Fulvestrant in Post-menopausal Women at Least 18 Years of Age With Advanced ER-positive HER2 Negative Breast Cancer (NCT04214288)AstraZeneca2020-04-22

Track Advanced ER-Positive HER2-Negative Breast Cancer automatically

Every clearance here is in the API, with alerts when new ones post.